Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    "Pterygium of the conjunctiva and cornea"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Randomized Controlled Trial of Subconjunctival Bevacizumab Injection in Impending Recurrent Pterygium
Condition: Pterygium of the Conjunctiva and Cornea
Interventions: Drug: Fluorometholone;   Drug: Bevacizumab

Indicates status has not been verified in more than two years